Ligand-Induced Proton Transfer and Low-Barrier Hydrogen Bond Revealed by X-ray Crystallography by Chen, Yunichols et al.
18 September 2017
intestazione repositorydell’ateneo
Ligand-Induced Proton Transfer and Low-Barrier Hydrogen Bond Revealed by X-ray Crystallography / Chen, Yunichols;
Hargis, Jacqueline C.; Sanishvili, Ruslan; Jaishankar, Priyadarshini; Defrees, Kyle; Smith, Emmanuel W.; Wang,
Kenneth K.; Prati, Fabio; Renslo, Adam R.; Woodcock, H. Lee; Chen, Yu. - In: JOURNAL OF THE AMERICAN
CHEMICAL SOCIETY. - ISSN 0002-7863. - STAMPA. - 137:25(2015), pp. 8086-8095.
Original
Ligand-Induced Proton Transfer and Low-Barrier Hydrogen Bond Revealed by X-ray Crystallography
Publisher:
Published
DOI:10.1021/jacs.5b00749
Terms of use:
openAccess
Publisher copyright
(Article begins on next page)
Testo definito dall’ateneo relativo alle clausole di concessione d’uso
Availability:
This version is available at: 11380/1069247 since: 2017-05-11T11:55:30Z
This is the peer reviewd version of the followng article:
  
This document is confidential and is proprietary to the American Chemical Society and its authors. Do not 
copy or disclose without written permission. If you have received this item in error, notify the sender and 
delete all copies. 
 
 
 
Ligand-induced proton transfer and low-barrier hydrogen 
bond revealed by X-ray crystallography 
 
 
Journal: Journal of the American Chemical Society 
Manuscript ID: ja-2015-007498.R2 
Manuscript Type: Article 
Date Submitted by the Author: 03-Jun-2015 
Complete List of Authors: Nichols, Derek; University of South Florida,  
Hargis, Jacqueline; University of South Florida, Department of Chemistry  
Sanishvili, Ruslan; Argonne National Laboratory,  
Jaishankar, Priyadarshini; University of California San Francisco, 
Pharmaceutical Chemistry 
DeFrees, Kyle; University of California San Francisco ,  Pharmaceutical 
Chemistry 
Smith, Emmanuel; University of South Florida, Department of Molecular 
Medicine 
Wang, Kenneth; University of South Florida, Chemistry 
Prati, Fabio; University of Modena and Reggio Emilia, Chemistry 
Renslo, Adam; UCSF, Pharmaceutical Chemistry 
Woodcock , H. Lee; University of South Florida, Chemistry 
Chen, Yu; University of South Florida,  
  
 
 
ACS Paragon Plus Environment
Journal of the American Chemical Society
	   1	  
	  
	  
	  
	  Ligand-­‐induced	  proton	  transfer	  and	  low-­‐barrier	  hydrogen	  bond	  revealed	  by	  
X-­‐ray	  crystallography	  	  	  
Authors:	  Derek	  A.	  Nichols1,	  Jacqueline	  C.	  Hargis2,	  Ruslan	  Sanishvili3,	  Priyadarshini	  Jaishankar4,	  Kyle	  Defrees4,	  Emmanuel	  Smith1,	  Kenneth	  K.	  Wang2,	  Fabio	  Prati5,	  Adam	  R.	  Renslo4,	  H.	  Lee	  Woodcock2,	  Yu	  Chen1*	  	  	  	  
Affiliations:	  	  1University	  of	  South	  Florida	  College	  of	  Medicine,	  Dept	  of	  Molecular	  Medicine,	  12901	  Bruce	  B.	  Downs	  Blvd,	  MDC	  3522,	  Tampa,	  FL	  33612	  	  2Department	  of	  Chemistry,	  University	  of	  South	  Florida,	  Tampa,	  Florida	  33620	  	  3GMCA@APS,	  X-­‐ray	  Science	  Division,	  Advanced	  Photon	  Source,	  Argonne	  National	  Laboratory,	  Argonne,	  Illinois	  60439	  	  4Department	  of	  Pharmaceutical	  Chemistry	  and	  Small	  Molecule	  Discovery	  Center,	  University	  of	  California	  San	  Francisco,	  1700	  4th	  Street,	  Byers	  Hall	  S504,	  	  San	  Francisco,	  CA	  941584	  	  5Department	  of	  Life	  Sciences,	  University	  of	  Modena	  and	  Reggio	  Emilia,	  Italy	  	  *	  To	  whom	  correspondence	  should	  be	  addressed.	  Phone:	  (813)	  974-­‐7809;	  Fax:	  	  (813)	  974-­‐7357	  ;	  E-­‐mail:	  	  ychen1@health.usf.edu	  	  	  	  	   	  
Page 1 of 33
ACS Paragon Plus Environment
Journal of the American Chemical Society
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
	   2	  
	  
Abstract: Ligand binding can change the pKa of protein residues and influence enzyme 
catalysis.  Herein, we report three ultrahigh resolution X-ray crystal structures of CTX-M 
β-lactamase, directly visualizing protonation state changes along the enzymatic pathway: 
apo protein at 0.79 Å, pre-covalent complex with non-electrophilic ligand at 0.89 Å, and 
acylation transition state (TS) analog at 0.84 Å.   Binding of the non-covalent ligand 
induces a proton transfer from the catalytic Ser70 to the negatively charged Glu166, and 
the formation of a low-barrier hydrogen bond (LBHB) between Ser70 and Lys73, with a 
length of 2.53 Å and the shared hydrogen equidistant from the heteroatoms.  QM/MM 
reaction path calculations determined the proton transfer barrier to be 1.53 kcal/mol.  The 
LBHB is absent in the other two structures although Glu166 remains neutral in the 
covalent complex.  Our data represents the first X-ray crystallographic example of a 
hydrogen engaged in an enzymatic LBHB, and demonstrates that desolvation of the 
active site by ligand binding can provide a protein microenvironment conducive to LBHB 
formation.  It also suggests that LBHBs may contribute to stabilization of the TS in 
general acid/base catalysis together with other pre-organized features of enzyme active 
sites.   These structures reconcile previous experimental results suggesting alternatively 
Glu166 or Lys73 as the general base for acylation, and underline the importance of 
considering residue protonation state change when modeling protein-ligand interactions.   
Additionally, the observation of another LBHB (2.47 Å) between two conserved residues, 
Asp233 and Asp246, suggests that LBHBs may potentially play a special structural role 
in proteins. 
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Introduction 
The protonation states of protein side chains dictate their roles in enzyme catalysis 
and ligand binding.  This information, while vital to the study of enzyme mechanisms and 
drug discovery, is challenging to obtain experimentally, especially for transient reaction 
intermediates. In particular, the binding of small molecules often modifies the protein 
microenvironment and consequently the pKa of catalytic residues.  Such effects can 
potentially promote proton transfer in a pre-covalent Michaelis complex and during 
general acid/base catalysis.  This perturbation may also induce the formation of a low 
barrier hydrogen bond (LBHB), where two functional groups with similar pKa’s equally 
share a proton, thus contributing to an unusually short (~2.5 Å), strong hydrogen bond 
(HB) 1.  Both experimental 2-5 and computational studies 6-9 support the notion of LBHBs 
in enzyme catalysis but X-ray crystallographic structural evidence has so far been elusive, 
primarily due to the experimental challenge of precisely locating hydrogen atom 
positions and the transient nature of catalytic LBHBs.  Meanwhile, opposing arguments 
supported by experimental and computational analysis have been put forward to 
challenge the existence of LBHBs in proteins and the contribution of such short LBHBs 
to enzyme catalysis10-14.   
CTX-M Class A β-lactamase, a member of the serine hydrolase superfamily, 
provides a suitable system for such investigation because its crystals can diffract to sub-
Angstrom resolution and small molecule inhibitors have been developed to probe 
relevant reaction intermediates 15,16. CTX-M, the most common clinically observed 
extended spectrum β-lactamase, has enhanced activity in hydrolyzing and deactivating 
third-generation cephalosporins, in addition to other common β-lactam antibiotics such as 
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penicillins 17,18.  The enzymatic mechanism includes acylation and deacylation steps, both 
involving proton transfer facilitated by general-acid/base catalysis.  In formation of the 
initial acyl-enzyme intermediate, Ser70 is deprotonated during its attack on the β-lactam 
substrate, with a subsequent proton transfer to the nitrogen atom of the scissile bond. 
Deacylation of the acyl-enzyme intermediate begins when a general base removes a 
proton from the catalytic water that serves as a nucleophile to react with the acyl-enzyme, 
releasing the hydrolyzed β-lactam and regenerating the free enzyme.  
One outstanding question of Class A β-lactamase catalysis is the identity of the 
general base in the acylation step; Lys73 and Glu166 have alternately been proposed to 
play this role 19-25. A quantum mechanics/molecular mechanics (QM/MM) approach 
employed by Mobashery and coworkers using TEM-1 Class A β-lactamase supports a 
concerted base hypothesis, in which substrate binding induces proton transfer from Ser70 
via the catalytic water to anionic Glu166 (Fig. 1) with simultaneous proton transfer from 
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Figure	  1.	   	   A	   concerted	  base	  hypothesis	   for	   the	  acylation	  half–reaction	  of	  Class	  A	  β-­‐lactamase	  
proposes	  protonation	  state	  changes	  prior	  to	  general	  acid/base	  catalysis.	  	  Beginning	  with	  the	  apo	  enzyme	   hydrogen	   bonding	   network	   (i)	   to	   a	   ground-­‐state	   Michaelis	   complex	   (ii),	   as	   predicted	   by	  QM/MM	  calculations.	   	  The	  binding	  of	   the	   substrate	   is	  proposed	   to	   change	   the	  protonation	   states	  of	  Ser70,	   Lys73	   and	  Glu166.	   	   A	   neutral	   Lys73	   then	   serves	   as	   the	   general	   base	   to	   activate	   Ser70.	   	   The	  remaining	  stages	  of	  catalysis	  (stages	  not	  shown)	  proceed	  through	  a	  high-­‐energy	  acylation	  transition	  state,	  to	  a	  low-­‐energy	  acyl-­‐enzyme	  intermediate.	  	  Subsequently,	  deacylation	  proceeds	  through	  a	  high-­‐energy	  transition	  state	  and	  on	  to	  a	  post-­‐covalent	  product	  complex.	  	  	  
i	   ii	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Lys73 to Ser70 26.  This produces a pre-covalent Michaelis complex in which all three 
residues (Ser70, Lys73 and Glu166) are neutral.  Neutral Lys73 will then deprotonate 
Ser70 during the nucleophilic attack on the β-lactam ring 26.  Confirmation of this 
hypothesis could potentially reconcile seemingly contradicting hypotheses suggesting 
alternatively Lys73 or Glu166 as the general base for the acylation reaction 19-25.  
However, verification remains an experimental challenge due to the necessarily transient 
nature of the Michaelis complex in the case of electrophilic (reactive) β-lactam substrates.  
 
Results 
Protonation state change and LBHB observed by X-ray crystallography 
Recently, we described a new class of potent but non-electrophilic inhibitors of 
CTX-M with activity in live bacteria 15.  We considered that these compounds, which 
interact with many of the same active site residues as β-lactam substrates, might serve to 
mimic the pre-covalent complex formed transiently with β-lactam substrates.  Using one 
of these new inhibitors and a previously described covalent boronic-acid based inhibitor, 
we have now elucidated three sub-Angstrom resolution X-ray crystal structures of CTX-
M-14, which together capture the first three stages of the enzymatic pathway: apo protein 
(0.79 Å), pre-covalent ligand complex (0.89 Å), and covalent transition-state analog for 
the acylation reaction (0.84 Å).  Many hydrogen atoms, including some on the ligand, can 
be identified using unbiased Fo-Fc difference maps calculated with the hydrogen-omitted 
model (Fig. 2).  Significantly, all hydrogen atoms on the polar residues constituting the 
catalytic machinery can be discerned unambiguously (Fig. 3A-C).   Hydrogen atoms are 
consistently observed in the same location, in both monomers in the asymmetric unit of 
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the P21 space group, and among data sets obtained from different crystals having similar 
resolutions (Supplementary Fig. 1).  
In the apo structure, Lys73 is protonated and donates a HB to Ser70, which in turn 
acts as a HB donor to the catalytic water (wat1, Fig. 3A).  This same water also donates a 
HB to Glu166, which is in the carboxylate form. These observations are in accord with a 
previously determined 0.88 Å resolution X-ray crystal structure of apo CTX-M-9, as well 
as a 0.90 Å resolution SHV-2 structure 16,21.  Interestingly, a very different hydrogen-
bonding network is observed in the complex with non-electrophilic inhibitor 1 (Fig 3B).  
A net transfer of a proton from Ser70 to Glu166 via the catalytic water has occurred, 
resulting in a neutral Glu166. Ser70 appears primed for reaction with substrate, and now 
accepts HB from the catalytic water, and is involved in a very short HB (at a length of   
Thr235	   Ser237	   Asp240	  
Pro167	  
Ser130	  
Thr235	   Ser237	  
Ser130	  
Ser70	  
Lys73	  
A)	   	  
1	   2	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N
H
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N
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HO OH
Figure	   2.	   	   Complex	   structures	   of	   CTX-­‐M	   β-­‐lactamase.	   The	   2Fo-­‐Fc	   (blue)	   and	   Fo-­‐Fc	   (red)	  electron	   density	   maps	   of	   the	   ligands	   are	   contoured	   at	   1.5	   and	   2	   σ	   respectively.	   	   The	   positive	  difference	   peaks	   indicate	   the	   positions	   of	   hydrogen	   atoms.	   (A)	   The	   non-­‐covalent	   complex	  with	  tetrazole-­‐based	  inhibitor	  1.	  The	  catalytic	  machinery,	  including	  Ser70	  and	  Lys73,	  is	  directly	  behind	  the	  ligand	  and	  isolated	  from	  the	  bulk	  solvent.	  (B)	  The	  complex	  structure	  of	  boronic	  acid	  inhibitor	  
2,	  mimicking	  the	  acylation	  transition	  state	  tetrahedral	  intermediate.	  	  	  	  
	  
B)	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Figure	   3.	   	  Proton	   transfer	   and	   short	   hydrogen	  
bond	   formation	   induced	   by	   ligand	   binding.	  	  Only	  the	  catalytic	  residues	  are	  shown.	  Wat1	   is	   the	  catalytic	   water.	   The	   2Fo-­‐Fc	   maps	   (blue)	   are	  contoured	  at	  1.5	  σ.	  The	  positive	  Fo-­‐Fc	  peaks	  (red,	  2	  σ)	   indicate	   the	   positions	   of	   hydrogen	   atoms.	   (A)	  Apo	   structure	   at	   0.79	   Å.	   (B)	   Structure	   of	   non-­‐covalent	  complex	  with	  compound	  1	  at	  0.89	  Å.	  The	  hydrogen	   between	   Ser70	   and	   Lys73	   is	   located	   at	  equal	   distances	   from	   the	   two	   electronegative	  atoms.	   (C)	   Structure	   of	   covalent	   complex	   with	  compound	   2	   at	   0.84	   Å.	   	   (D)	   Three	   structures	  superimposed,	   showing	   the	   movement	   of	   Lys73	  (apo,	   magenta;	   non-­‐covalent	   complex,	   yellow;	  covalent	   complex,	   cyan).	   The	   arrows	   indicate	  residue	  movements	   from	   the	   apo	   structure	   to	   the	  two	  complexes.	  	  	  
Ser70	  
	  
	  	  	  wat1	  
	  	  	  Lys73	  
Asn170	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C)	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Page 7 of 33
ACS Paragon Plus Environment
Journal of the American Chemical Society
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
	   8	  
 
2.53 Å) with Lys73.  This protonation state is essentially the same as that predicted 
previously by QM/MM for the pre-covalent Michaelis complex, with one unexpected and 
subtle difference.  Notably, the Fo-Fc and 2Fo-Fc maps reveal that the hydrogen atom 
shared by Lys73 and Ser70 is equidistant (1.3 Å) from the two heteroatoms, Lys73Nζ 
and Ser70Oγ, meeting a key criteria for a LBHB (Fig. 3B, 4A) 13.  The observation of this 
hydrogen in the 2Fo-Fc map indicates that it is as highly ordered as the hydrogens which 
are covalently bound to Ser70Cβ and other carbon atoms in the vicinity (Fig 4A). Its 
location exactly at the center of the HB between Ser70 and Lys73 is observed in both 
monomers of the asymmetric unit and also in a second structure solved to similar 
resolutions (Supplementary Fig. 1).   
Figure	  4.	  	  Hydrogen	  atoms	  captured	  in	  2Fo-­‐Fc	  electron	  density	  maps.	  The	  small	  isolated	  peaks	  indicate	  well-­‐ordered	  hydrogen	  atoms	  on	   carbon	  atoms	  and	  two	  hydrogens	   involved	   in	  LBHB.	  The	  maps	  are	  contoured	  at	  0.5	  σ	  to	  show	  the	  center	  of	  those	  peaks	  for	  LBHB	  hydrogens	  and	  to	  eliminate	  background	   noise.	   More	   protons	   can	   be	   identified	   in	   Fo-­‐Fc	   maps	   (not	   shown	   here).	   (A)	   LBHB	  between	  Lys73	  and	  the	  catalytic	  Ser70	  in	  the	  active	  site.	  The	  angles	  involving	  the	  HB	  are	  ∠	  Ser70Cβ-­‐Ser70Oγ-­‐H	  (111.7°),	  ∠	  Ser70Oγ-­‐H-­‐Lys73Nζ	  (175.4°),	  and	  ∠	  H-­‐Lys73Nζ-­‐Lys73Cε	  (114.5°).	   (B)	  LBHB	  involving	  Asp233	  and	  Asp246.	   	  Both	  residues	  are	  buried	  with	  Asp233	  near	   the	  protein	  surface	  but	  shielded	  from	  bulk	  solvent	  by	  Arg222	  in	  the	  crystal	  structures.	  	  	  Asp246	  is	  located	  deeper	  and	  closer	  to	   the	   protein	   core,	   and	   is	   replaced	   by	   an	   isoleucine	   in	   some	   Class	   A	   β-­‐lactamases.	   	   	   The	   angles	  involving	  the	  HB	  are	  ∠	  Asp233Cγ-­‐Asp233Oδ1-­‐H	  (113.9°),	  ∠	  Asp233Oδ1-­‐H-­‐Asp246Oδ2	  (167.0°),	  and	  	  
∠	  H-­‐Asp246Oδ2-­‐Asp246Cγ	  (116.9°)	  
2.47	  Å	  
Asp246	  
Asp233	  
A)	   B)	  
Ser70	  
	  	  	  	  	  	  	  
	  	  	  	  	  	  	  2.53	  Å	  
	  	  	  	  	  Lys73	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The ability of 2Fo-Fc map to discern highly ordered hydrogens allowed the 
identification of a second LBHB between two buried aspartate residues (Asp233 and 
Asp246). This LBHB, unlike the one in the active site, is present in all three structures, 
and will be discussed more fully later (Fig. 4B).  Aside from the HBs with the catalytic 
water and Lys73, Ser70Oγ accepts a third HB from the water molecule in the oxyanion 
hole (wat4). This HB shortens from 2.85 Å in the apo structure to 2.59 Å in the non-
covalent complex. This shortening may reflect an increase in the partial negative charge 
on Ser70Oγ in the non-covalent complex with 1. The unusually close HB interaction with 
wat 4 possibly mimics the approach of nucleophilic Ser70Oγ to the electrophilic carbonyl 
carbon of a bound β-lactam substrate, which would place the carbonyl group roughly in 
the position of wat 4.  In all, Ser70Oγ functions as acceptor in two HBs in addition to the 
LBHB with Lys73.  None of the hydrogen atoms in these three HBs is within covalent 
bond distance to Ser70Oγ.  Although we cannot exclude the possibility that the hydrogen 
of a protonated Ser70 is simply not observable in the electron density map, we deem this 
highly unlikely considering Ser70Oγ is already surrounded by three close HB donors.   
Moreover, as reported earlier in another ultrahigh resolution structure, hydrogen 
“visibility” inversely correlates with the temperature factor (B factor) of the heavy atom 
to which it is bound 27. The B factor of Ser70 Oγ (7.67 Å2) is similar to that of Lys73 Nζ 
(7.53 Å2) and wat4 (7.31 Å2) and lower than those of Glu166 Oε1 (8.38 Å2) and wat1 
(9.32 Å2), all of which are in the vicinity and whose covalently bound hydrogens are 
clearly visible in Fo-Fc maps (Fig. 3B).  
Boronic acid inhibitors like 2 are often employed to mimic the acylation transition 
state, since they will react with the catalytic serine to form a tetrahedral boronate 
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adduct.20  In our structure of covalently bound 2, Glu166 is neutral while Lys73 is 
protonated (charged) and moves away from the Ser70-boronate adduct and closer to 
Ser130 (Fig 2B).  Ser130 is well positioned to mediate proton transfer to nitrogen in the 
tetrahedral intermediate of a β-lactam substrate, which is mimicked by a boronate oxygen 
in the complex with 2 (Fig. 2B).  That Glu166 is indeed protonated in complexes with 1 
and 2 is further supported by the Cδ-Oε1 bond length, which is 1.26 Å in the apo 
structure and 1.31 Å in the structures with 1 and 2 (Supplementary Table 1).  They also 
agree with the 0.85 Å resolution X-ray structure of TEM-1 20 and the 2.0 Å resolution 
neutron structure of Toho-1 28, a CTX-M family member, both in complex with a boronic 
acid covalent inhibitor.  In addition to the previously discussed LBHB in the non-
covalent complex with 1, the HB between Glu166 and the catalytic water also appears to 
be short in both the complexes with 1 and 2, at a distance of 2.55 Å.  However, the shared 
hydrogen atom, which is clearly visible in the Fo-Fc maps, is covalently bound to Oε1 of 
Glu166 in both complexes.  Among the close, strong hydrogen bonds in the active site, 
only the HB between Ser70 and Lys73 exhibits all the characteristics of a LBHB.   
 
Protonation state change and LBHB suggested by QM/MM 
The protonation state of Glu166 in complex with 1 agrees with the QM/MM 
predictions of Mobashery et al 26, highlighting the increasing sophistication and maturity 
of computational modeling in making meaningful predictions for enzyme catalysis.  
Although this previous study did not investigate the possibility of a LBHB between Ser70 
and Lys73, the results did indicate that this HB can be as short as 2.5 Å.  Moreover, the 
QM/MM calculations predicted that the charged (Lys73-NH3)+-(Ser70-O)- pair will 
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become neutral (Lys73-NH2)-(Ser70-OH) upon β-lactam substrate binding, and that the 
proton on Ser70 will transfer to Lys73 as Ser70 attacks the substrate 26. We previously 
performed a QM/MM investigation of CTX-M with the non-covalent β-lactam substrate 
cefoxitin 29. Two protonation state combinations were examined as a function of altering 
the Lys73 and Glu166 protonation state. Upon examining orbital interactions and active 
site reorganization, we were able to confirm the hypothesis that Lys73 and Glu166 are 
neutral in the presence of a substrate, concordant with the experimental observations 
presented here.  
While previous computational results align well with the present work’s 
experimental findings 26, the differences between TEM-1 and CTX-M warrant additional 
investigations that focus on effects induced by the non-covalent inhibitor, the LBHB, and 
additional water molecules in the active site. To better corroborate experimental findings 
related to the microenvironment fluctuation, 11 ns molecular dynamics (MD) simulations 
were performed on three unique protonation state combinations for the CTX-M active 
site for the complex with 1. Three states were created to capture the effects that occur in 
the non-covalent inhibitor complex: state I, Ser70 - negatively charged, Glu166 - neutral, 
and Lys73 - positively charged; state II,  Ser70 - neutral, Glu166 - neutral, Lys73 - 
neutral; and state III, Ser70 - neutral, Glu166 - negatively charged, and Lys73 - 
positively charged. Additionally, an apo state was prepared mimicking protonation state 
III.  
For states I and II, the average distance between Lys73Nζ and Ser70Oγ for the 
11 ns simulation is 2.55 Å and 2.53 Å, respectively, while for state III the average 
distance is 2.88 Å in the complex with 1. These results concur with the experimental 
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findings that Glu166 is neutral in the non-covalent inhibitor complex. Further, this 
evidence agrees with the formation of the LBHB in the non-covalent complex, while the 
purposefully incorrect protonation state combination (III) shows that the LBHB does not 
occur arbitrarily.  Additionally, the average distance of 2.87 Å between Lys73Nζ and 
Ser70Oγ in the simulation of the apo state is in good agreement with the apo crystal 
structure. 
To better understand the Ser-Lys LBHB, QM/MM calculations were performed to 
predict the location of the hydrogen atom between Lys73 and Ser70 in addition to the 
barrier height of the proton transfer. The initial QM/MM minimized structure confirms 
that the hydrogen energetically prefers being bonded to Ser70. However, due to the 
transient nature of LBHBs a closer look at the reaction barrier is warranted, and was 
performed using the QM/MM replica path (RPATH) plus restraint distance (RESD) 
method 30-34. The replica framework allows the system to be partitioned into three regions: 
the QM region (the non-covalent inhibitor, Glu166, Ser70, Lys73, Ser130, Lys234, 
Thr235, Gly236, Ser237, wat1, and wat4), the replica region, and the MM region. The 
QM region is treated quantum mechanically and is where the reaction occurs; the replica 
region (i.e. everything within 6.5 Å of the QM region) is re-minimized with MM as a 
function of the reaction’s propagation in the QM region. Finally, the third partitioned 
region is calculated via MM and is treated consistently throughout the reaction. The 
RESD method is utilized in the replica framework and uses a linear combination of 
distances to drive the movement of the hydrogen atom between Ser70 and Lys73 in 
increments of 0.10 Å. The energy is computed at each point of the pathway with a 
correction applied to replicate high level ab initio barriers for LBHBs35. The computed 
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barrier is 1.53 kcal/mol, which is well under the threshold that typically indicates a 
Figure	  5.	  	  QM/MM	  Transition	  State	  and	  Reaction	  Pathway.	  	  	  QM/MM	  Replica	  path	  +	  Restraint	  Distance	  calculations	  determined	  the	  proton	  transfer	  barrier	  occurring	  between	  Ser70	  and	  Lys73.	  	  A)	  The	  transition	  state	  of	  the	  proton	  transfer	  with	  the	  proton	  located	  in	  the	  middle	  between	  the	  two	  electronegative	  atoms.	  	  Wat1	  is	  the	  catalytic	  water	  and	  wat4	   is	  located	  in	  the	  oxyanion	  hole	  formed	   by	   the	   backbone	   amide	   groups	   of	   Ser70	   and	   Ser237.	   	   Ser70	   is	   positioned	   at	   the	   N-­‐terminus	   of	   a	   helix.	   	   B)	   The	   reaction	   path	   plotted	   as	   a	   function	   of	   the	  QM/MM	   energy	   for	   the	  proton	  transfer	  barrier.	  The	  hydrogen	  is	  moved	  from	  Ser70	  (0.0	  Å)	  to	  Lys73	  (0.8	  Å).	  	  
N
H
H
H
Lys73
O
Ser70
N
H
H
H
Lys73
O
Ser70
Ser70	  
Lys73	  
Glu166	  
	  	  	  	  Asn170	  
	  	  	  	  	  	  	  wat1	  
	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  Ser237	  
	  	  	  	  	  	  Ser130	  
	  	  	  	  	  	  	  wat4	  
	  	  	  	  	  	  	  A)	  
	  	  	  	  	  	  	  B)	  
 
  Å	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LBHB (Fig. 5). Further, it has previously been shown that the zero point vibrational 
energy (ZPVE) for LBHBs is approximately 1-2 kcal/mol35.  Upon applying the typical 
LBHB ZPVE to the present system, the barrier is estimated to be ~0.5 kcal/mol. This is 
lower than kT (0.593 kcal/mol) suggesting that the barrier is thermal and a continuum of 
states is possible, corroborating experimental evidence.  Additional computational 
evidence also indicates the importance of the enzyme for the formation of the LBHB.   
Upon computing the proton transfer pathway using only the QM region (i.e., eliminating 
the MM protein environment), there is a monotonic energy increase of 7.6 kcal/mol as the 
hydrogen moves from Ser70 to Lys73, suggesting that one protonation state is now 
energetically much more favored than the other.   
 
LBHB in activating a nucleophilic serine in general base catalysis 
The sub-Angstrom resolution crystal structures provide for the first time the 
experimental evidence to reconcile several decades’ mutagenesis/biochemical data and 
the seemingly contradicting hypotheses on the identity of the general base for the 
acylation reaction of Class A β-lactamases.   Although Glu166 is involved in a proton 
transfer upon initial ligand binding, Lys73 appears to be the actual general base activating 
the nucleophilic Ser70 in the pre-covalent complex.  The conformational changes of 
Lys73 in our three structures seem to track the reaction coordinates, consistent with its 
proposed role at different stages of the reaction (Fig. 3D).  Previous kinetic isotope effect 
(KIE) studies and QM/MM calculations suggest that the formation of the tetrahedral 
transition state is the rate-limiting step of the acylation reaction during Class A β-
lactamase catalysis26,36.  More specifically, general base catalysis is required to initiate the 
Page 14 of 33
ACS Paragon Plus Environment
Journal of the American Chemical Society
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
	   15	  
formation of this tetrahedral TS, whereas general acid catalysis is involved in the collapse 
of the TS.  We propose that our non-covalent complex with 1 captures a reaction state en 
route to the tetrahedral TS (rather than the ground-state Michaelis complex), and 
involving general base catalysis (Fig. 3B).  After Glu166 extracts the proton from Ser70 
through the catalytic water, Lys73 moves closer to Ser70 and lowers the energy barrier of 
the TS formation through a LBHB (Fig. 3D).  In comparison, our covalent complex with 
2 mimics a reaction state preceding collapse of the tetrahedral TS (rather than the real 
TS), when general acid catalysis takes place (Fig. 3C).  The Lys73 side chain swings 
further away from Glu166 and closer to Ser130 (Fig. 2B, 3D), which donates a proton to 
the ring nitrogen of the substrate and promotes the collapse of the tetrahedral TS.   
QM/MM calculations have also suggested that, after transferring a proton to Ser130, 
Lys73 would move back to and extract the proton from Glu166, activating the latter for 
the deacylation step 26. Additionally, other active site features, such as the oxyanion hole 
formed by the backbone amide groups of Ser70 and Ser237, also make important 
contributions to the stabilization of the TS during this process. 
The experimentally observed LBHB between Ser70 and Lys73 suggests the 
importance of Lys73 in stabilizing the nucleophilic serine in preparation for its attack on 
the β-lactam substrate.   It has long been hypothesized but also a matter of debate that 
LBHBs can supply up to 10-20 kcal/mol of free energy for enzymatic reactions, 
significantly higher than approximately 3-5 kcal/mol for a standard HB 1,4.   A recent 
study has suggested that LBHBs can play a special role in enzyme catalysis to the extent 
the semi-solid and weakly-polar character of an enzyme active site can support a LBHB 
with a reasonable fraction of the strengths found in the gas phase 3.  The existence of such 
Page 15 of 33
ACS Paragon Plus Environment
Journal of the American Chemical Society
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
	   16	  
LBHBs in proteins however, has been subject to intense debate, partly due to the lack of 
direct observation by X-ray crystallography 37,38.  Our structures not only represent the 
first observation of a hydrogen engaged in such a LBHB by X-ray crystallography, but 
also demonstrate that ligand binding itself can induce the formation of a LBHB, as 
suggested by previous NMR studies in other systems 1,2,4.  We acknowledge that the 
crystalline environment can be different from solution.  However, the fact that the LBHB 
is observed only in one of three structures obtained under the same crystallization 
conditions and is confirmed by computations in the present work suggests that a suitable 
microenvironment is necessary and sufficient for LBHB formation, and that the observed 
LBHB is not a crystallization artifact.  Ultrahigh resolution X-ray crystal structures have 
been previously determined for other serine-based enzymes, such as the 0.78 Å apo 
subtilisin and 0.83 Å α-lytic protease bound by a covalent boronic acid inhibitor 39,40. 
However, in these previous cases the proposed His-Asp LBHB appeared to be a short 
asymmetric HB based on both the HB lengths (2.62/2.77 Å) and the hydrogen positions 
39,40, although in apo subtilisin, the histidine Nδ1-H bond of the HB donor appears 
slightly lengthened (1.2 Å).   The catalytic serine is not involved in any LBHB in either 
of these two structures, similar to our apo and covalent complex structures. 
It should be pointed out that more experimental evidence is needed to demonstrate 
the existence of a Lys73-Ser70 LBHB during the actual reaction pathway of Class A β-
lactamase.  If verified, the exact energetic contribution of this LBHB to catalysis still 
needs to be studied, computationally or experimentally.  Whereas we interpreted the two 
complex structures in the context of the proposed reaction pathway, the structures might 
have instead captured states not relevant to the hydrolysis reaction. In particular, the 
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LBHB we observed may be specifically induced by the non-covalent ligand used in our 
studies but not by the substrate.   Previous QM/MM calculations also supported a 
competing acylation pathway using Glu166 and the catalytic water as the general base, 
with an energy barrier only 4 kcal/mol higher than the neutral Lys73 pathway discussed 
above.  However, the agreement between the structural details of our complexes and 
previous experimental and computational results seem to favor Lys73 as the general base 
in the substrate complex  19,23,24,26.   Whereas we believe the unique features of the 
compound are crucial in allowing us to trap such a stable LBHB in an otherwise usually 
transient state during catalysis, many of the key features, such as a partially negatively 
charged ring nitrogen, are also shared by the substrate and may hence be catalytically 
relevant.   
 
LBHB in maintaining protein structure 
The studies of LBHBs have so far only focused on their potential contribution to 
enzyme catalysis. In addition to the Ser70-Lys73 LBHB in the active site, we have also 
observed a LBHB in a near-surface yet buried region of the CTX-M protein between 
Asp233 and Asp246, present in all three structures.  Again, we are able to observe the 
hydrogen shared by these two residues in the 2Fo-Fc density map, with a distance of 2.47 
Å between the two heteroatoms (Fig. 4B). Asp233 and Asp 246 are highly conserved in 
Class A β-lactamases 41-43.  Based on the HB distance between these two residues, it 
appears that the LBHB may be present in many other Class A β-lactamases 16,44.  Because 
the two aspartate residues are located outside the active site, we suspect that the LBHB 
may be important for protein stability and may even play a role in protein folding.  
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Interestingly, in a few enzymes where Asp246 is replaced by isoleucine, an alternative 
short hydrogen bond is formed between Asp233 and Asp214 (Asn214 in CTX-M) 20,21.  It 
should be noted that hydrogen-mediated Asp-Asp pairs are commonly observed in 
proteins with some hypothesized to play a catalytic role as well 45.   These observations, 
together with previous studies on enzymes such as HIV protease and other Asp/Glu based 
enzymes, suggest that LBHB might play a common role in protein structure and function 
45,46	  .  Ground-state and structural LBHBs, such as the one between Asp233 and Asp246, 
may offer valuable insights into the steric and energetic requirements for LBHB 
formation in proteins. 
 
 
Discussion 
The three ultrahigh resolution structures offer valuable insights into the protein 
microenvironment upon small molecule binding.  These results have important 
implications for our understanding and modeling of protein-ligand interactions in enzyme 
catalysis, protein engineering and drug discovery.  Non-covalent inhibitors are the focus 
of many structure-based ligand development approaches in the search for new drugs and 
chemical probes.  In these computational modeling experiments, the effects of non-
covalent ligand binding on residue protonation states are often ignored, particularly for 
side chains that do not form a direct HB with the ligand.  None of the catalytic residues 
(i.e., Ser70, Lys73, and Glu166) establishes a HB with the non-covalent inhibitor, yet all 
undergo a protonation state change due to ligand binding. Additionally, there is no net 
proton gain/loss in the active site during the binding event, so the protonation state 
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changes may not be captured by indirect methods such as ITC 47.  Both the experimental 
and computational data presented here suggest that virtual screening may potentially 
benefit from QM/MM methods in analyzing possible protonation state changes upon 
ligand binding 29. 
The non-covalent CTX-M complex also answers the long-standing question of 
whether and how a LBHB can exist in a protein active site.   The formation of a LBHB 
has several electrostatic and steric requirements.  First, the two hydrogen bonding 
functional groups should have similar pKa’s.  In aqueous solution, the pKa of serine 
hydroxyl group is approximately 3 units higher than that of lysine amino group.  
However, in Class A β-lactamases, Ser70 resides at the N-terminus of a long stretch of α-
helical structure (residues 69-87) and in close proximity to the oxyanion hole formed by 
the backbone amide groups of itself and Ser237 (Fig. 5A).  In a few of our unpublished 
E166 mutant structures, Ser70’s hydroxyl group is observed inside the oxyanion hole, 
suggesting transient HBs may be formed between Ser70 and the protein backbone in 
solution.  Based on previous studies, this influence by the protein backbone, including 
both the dipole and the direct HBs, can significantly reduce the pKa of Ser70 side chain 
and bring it close to that of Lys73 48.  A second important contributing factor to LBHB 
formation is desolvation of the active site upon binding 1.  LBHBs are not stable in bulk 
solvent because solvation effects from water would increase the charge separation 
between the two functional groups otherwise involved in LBHB, promoting proton 
transfer from one to the other 49.  These effects are likely to play a more important role in 
LBHBs where the two resonance structures (before vs after the proton transfer)have 
different electrostatic properties (e.g., (Lys73-NH3)+-(Ser70-O)- vs (Lys73-NH2)-(Ser70-
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OH)), in comparison to those with two very similar or even identical resonance structures 
(e.g., (Asp233-COOH)-(Asp246-COO)- vs (Asp233-COO)--Asp246-COOH)). A recent 
study has demonstrated that changes in solvent dielectric (e.g., water vs chloroform) do 
not significantly affect HB lengths in small-molecule model systems50, suggesting that 
desolvation of a protein binding pocket cannot alone account for LBHB formation.  As 
the authors note however, many protein binding sites (and catalytic sites in particular) are 
far from a homogeneous low-dielectric environment.  Rather, catalytic sites in particular 
possess a highly orchestrated arrangement of hydrogen bonds and dipolar or charged 
groups that, together with desolvation, serve to alter the pKa values of side chain residues 
and in specific cases reduce ΔpKa values such that LBHB formation is enabled.  In our 
protein, despite the observation of two structural waters including the catalytic water 
bound by the catalytic residues, the binding of the non-covalent inhibitor 1 completely 
isolates the CTX-M active site from bulk solvent (Fig. 5A). This effect is illustrated by 
the loss of the HB between the catalytic water (wat1) and the water molecule (wat2) 
closer to bulk solvent in the apo structure (Fig. 3A).  Additionally, the binding of both the 
non-covalent and covalent inhibitors causes a slight contraction of the active site, as 
shown by the small movement of the catalytic water (1.2 Å) and of Glu166 and Asn170 
(0.5-0.6 Å) (Fig. 3D).  This slightly higher compactness of the active site squeezes out 
the water (wat3) shared by Lys73 and Glu166 in the apo structure (Fig. 3A).  Lastly, 
despite the compactness of the active site, small movements of Ser70 and Lys73 side 
chains in concert with adjustments in other polar interactions appear to be sufficient to 
allow these residues to adopt the optimal geometry necessary for LBHB formation.   
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For serine-based enzymes, Cleland and Kreevoy previously hypothesized that a 
direct LBHB between the general base and the nucleophilic serine can stabilize the 
activated serine during its attack on the substrate, while conceding that this LBHB might 
be difficult to capture by experiment due to its transient nature 1.   Our non-covalent 
complex offers the first, albeit slightly complicated, example of such a LBHB due to the 
concerted base mechanism involving both Glu166 and Lys73. During the acylation 
process and immediately following ligand binding, Glu166 is responsible for the initial 
deprotonation of Ser70 while Ser70 concurrently takes a proton from Lys73.   However, 
if we only consider the pre-covalent intermediate with neutral (Lys73-NH2)-(Ser70-OH) 
as predicted by previous QM/MM calculations 26, Lys73 is the de facto general base and 
clearly plays a more important role in this process.  In fact, neutral Lys73 has been shown 
by biochemical analysis and NMR to function as a general base for acylation in E166A 
mutants of Class A β-lactamases like TEM-1, as well as in penicillin-binding proteins 
(PBPs), the bacterial target of β-lactam antibiotics. 23,51 Serine β-lactamases have evolved 
from PBPs and the two groups of enzymes often share the same catalytic residues 52.  One 
of the only, and significant, exceptions is Glu166, which is unique for Class A β-
lactamases and essential for their ability to catalyze the deacylation step of β-lactam 
hydrolysis.  The E166A mutant β-lactamases are defective in the deacylation reaction, 
similar to the PBPs.  As previously discussed by others, Glu166’s role in the complicated 
acylation mechanism may have been an evolutionary relic instead of a catalytic necessity 
26. Because Glu166 is neutral in the non-covalent complex, its influence on neighboring 
residues’ pKa is reduced compared with a charged Glu166 in the apo state.  It is likely 
that the electrostatic microenvironment of the pre-covalent Michaelis complex is similar 
Page 21 of 33
ACS Paragon Plus Environment
Journal of the American Chemical Society
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
	   22	  
between Class A β-lactamases and PBPs.   We therefore hypothesize that a LBHB 
between the equivalents of Ser70 and Lys73 may also play an important role in the 
catalysis of at least some PBPs, including their inhibition by β-lactam antibiotics.  
Moreover, as nucleophilic serine is used to catalyze a wide range of enzymatic reactions 
by forming a covalent intermediate with the substrate, it is possible that similar LBHBs 
are present in other enzymatic reactions, as previously hypothesized 1,4,53.   
It is worth noting that even the strongest critics of the LBHB hypothesis 
acknowledge that LBHB may be involved in catalysis by specific enzymes.  Their key 
criticism centers on whether LBHBs or other preorganized active site features are the 
main stabilizing factor of enzyme catalysis49,54.   Our structures suggest that the reaction 
catalyzed by Class A β-lactamases may utilize both a LBHB (between Ser70 and the 
general base in the substrate complex, Lys73) and preorganized polar groups, such as the 
oxyanion hole formed by the backbone atoms of Ser70 and Ser237.  Importantly, the non-
covalent complex structure offers insights into the polarity of the enzyme active site that 
has been much debated in previous discussions55.  Together with two QM/MM 
calculations, the experimental structure demonstrates that the desolvated enzyme active 
site is only weakly polar and favors less net-charge separation in side chain functional 
groups, resulting in the protonation state changes in Glu166, Lys73 and Ser70.   A LBHB 
not only can exist in this environment in the presence of the right substrate/ligand, but 
also may contribute to a lower-energy TS by further reducing the negative charge 
accumulation on the tetrahedral intermediate.  In the absence of the LBHB between Ser70 
and the general base Lys73, the tetrahedral TS oxyanion has a net charge of -1.  With the 
LBHB, Ser70 is only partially deprotonated and the TS oxyanion has a net charge of 
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approximately -1/2 if it occurs in the midst of the proton transfer.  We therefore suggest 
that LBHB involving proton transfer in progress can indeed be a unique feature of 
enzyme catalysis by altering the TS in the weakly polar protein microenvironment, in 
comparison to reaction pathways where the proton transfer is completed prior to the TS.  
We postulate that this mechanism may be broadly employed by enzymes in general 
acid/base catalysis with conducive electrostatic/steric microenvironments in the active 
site, similar to previous hypotheses 53,56.   However, the exact energetic contribution of 
this LBHB to enzymatic general catalysis remains to be studied in detail, particularly in 
comparison to other short HBs.   Previous studies have demonstrated a continuum of 
short hydrogen bonds from short ionic HBs where the hydrogen is clearly covalently 
bonded to one heteroatom, HBs with partially delocalized hydrogens (lengthened bond 
length between the hydrogen and the heteroatom), symmetrical LBHBs with two 
potential energy minima separated by a shallow barrier along the HB, to single-well HB 
56,57.  It is likely that there is a continuum of energy contribution from these different HBs 
to catalysis including general catalysis, depending on the specific reaction mechanism.   
In summary, the three sub-Angstrom resolution structures of CTX-M presented 
here have captured protonation state changes and LBHB formation induced by non-
covalent ligand binding. Although these studies cannot resolve all of the controversy 
surrounding the role of LBHBs in enzyme catalysis, they do suggest that LBHBs can be 
induced by a conducive protein microenvironment in particular enzymes.  More 
specifically, the results support a 20-year old hypothesis by Cleland and Kreevoy that a 
transient and direct LBHB can be used to stabilize an activated nucleophilic serine in its 
attack on a substrate 1.  The protonation state change induced by both non-covalent and 
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covalent inhibitors has important implications for how we simulate protein-ligand 
interactions in molecular docking and may lead to better performance of structure-based 
approaches in drug discovery and enzyme engineering.   
	  	  	  
Methods 
 
Protein purification, crystallization and structure determination 
To improve crystal qualities and diffraction resolutions and to ensure full ligand 
occupancies, we tested in our experiments multiple proteins and purification protocols 
(CTX-M-9, His-tag CTX-M-9, codon-optimized CTX-M-9 without signal peptide, CTX-
M-14), different crystallization conditions and crystal forms (space group P212121 at pH 
3.0-5.5, P21 and P3221 at pH 7.9-8.7), various procedures to prepare complex crystals 
(co-crystallization, and soaking at different compound concentrations and for varying 
lengths of time), four non-covalent and four covalent inhibitors, and multiple beamlines 
and data collection strategies.  Approximately 200 crystals were screened for X-ray 
diffraction and 20 Sub-Angstrom resolution data sets were analyzed.   
In the final optimized protocol, CTX-M-14 was used to represent the CTX-M 
family.  The protein was purified as previously described 58 and crystallized in 1.0-1.2M 
potassium phosphate buffer (pH 8.3) from hanging drops at 20°C.  At pH 8.3, CTX-M-14 
retains half of its activity (kcat/Km) compared with pH 7.0, suggesting that the protonation 
states of active site residues should not differ significantly between the two pHs.  This is 
consistent with the fact that β-lactamases need to function over a range of pHs in the 
fluctuating environments of bacterial periplasm. The final concentration of the protein in 
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the drop ranged from 6.5 mg ml-1 to 10 mg ml-1.  The non-covalent complex crystals were 
obtained through soaking methods, with compound concentrations of 5.0mM and soaking 
times ranging from approximately 24 to 48 hours.  The complex crystals with the boronic 
acid inhibitor LP06 were obtained with co-crystallization with the protein, with the final 
concentration of the compound in the drop at 5.0mM.  Diffraction was measured at two 
beamlines:  8.3.1 at Advanced Light Source (ALS), Berkeley, California and 23-ID-B of 
GM/CA@APS at Advanced Photon Source (APS), Argonne, Illinois.  Data were indexed, 
scaled and merged with HKL2000 59.  The apo and complex structures were refined with 
SHELX97 60.  Model rebuilding was performed using Coot 61. Electron density maps 
were generated using SHELXPRO with the sharpening option.  The figures were 
generated using PyMOL 62.  Ligand occupancy was refined for all complex structures and 
was observed to be at or near 100% (98%-103%) for all the ligands in the active site.  For 
the non-covalent complex, a second copy of the ligand was observed stacking on top of 
the one inside the active site, a crystallization artifact due to the high compound 
concentrations used to ensure full ligand occupancy.  This artifact, however, does not 
affect the active site hydrogen bonding network when compared to the same complex 
prepared using lower inhibitor concentrations, based on the bond and HB lengths of 
active site residues in the presence and absence of the second copy of the inhibitor.  The 
second copy of the inhibitor also resides outside the active site and does not form any 
interactions with the active site residues.   
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Computational methods and pathway determination 
 The cocrystallized non-covalent structure of the tetrazole-based inhibitor and 
CTX-M β-lactamase (PDB:4UA7) was initially processed using www.charmming.org 63. 
CHARMM 31 c36a6 was used to prepare the protein, add hydrogens, and assign ionizable 
protonation states 64,65. Parameters for the non-covalent inhibitor were obtained from 
paramchem.org, which were reordered to satisfy the requirements of the Domain 
Decomposition (DOMDEC) 66 molecular dynamics (MD) parallelization module in 
CHARMM. Three protonation state combinations were created using the PATCh 
command to best capture active site behavior: state I --- Ser70: negatively charged side 
chain (deprotonated), Glu166: neutral, and Lys73: positively charged side chain 
(protonated); state II --- Ser70: neutral, Glu166: neutral, Lys73: neutral; and state III --- 
Ser70: neutral, Glu166: negatively charged side chain (deprotonated), and Lys73: 
positively charged side chain (protonated). Additionally, an apo state was prepared 
mimicking protonation state III. The CHARMM22 67 and CHARMM36 68 generalized 
force fields (C22 and CGenFF) were used in combination with the FLEXible parameter 
reader. The protein, crystallized waters, and non-covalent inhibitor were appended 
together, which was followed by an initial steepest descent minimization (200 steps) 
where all heavy atoms in the protein and ligand were fixed. The structures were solvated 
in a cubic water box using TIP3P waters. Again this was followed by a partial steepest 
descent minimization of 50 steps allowing the system to relax. Solvation was followed by 
an iterative Monte Carlo neutralization of the system where water molecules were 
replaced by potassium and chloride ions at random to yield a charge neutral system with 
a final salt concentration of 0.15 M.  Following each iteration a short minimization (25 
Page 26 of 33
ACS Paragon Plus Environment
Journal of the American Chemical Society
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
	   27	  
steps) was performed and compared to previous steps. After four iterations, the lowest 
energy structure was retained and minimized using the adopted basis Newton-Raphson 
(ABNR) method to a gradient tolerance of 0.001 kcal/mol•Å where all bonds involving 
hydrogen were fixed. The minimized structure was heated from 110.15 K to 310.15 K 
(body temperature) over 100 ps. Finally the system was equilibrated for 11 ns using 
DOMDEC at constant pressure (1 atm) and temperature (310.15 K).  
Following the MD simulations, extensive RMSD and distance analysis were 
performed. A representative structure (based on side chain distances) was chosen and 
minimized using a hybrid quantum mechanics/molecular mechanics (QM/MM) potential 
until a 0.005 kcal/mol•Å rms gradient tolerance was achieved. During the minimization 
the non-covalent inhibitor, Glu166, Ser70, Lys73, Lys234, Thr235, Gly236, Ser237, 
H2O26, and H2O45 were included in the QM region. Link atoms were placed between 
residues and two atoms in the residue specified in the following notation: residue number 
QM atom/MM atom (standard topology notation). Here are the link atom cuts for the QM 
region in the present work: 233 C/CA, 238 CA/C, 69 C/CA, 74 CA/CB, 74 CA/C, 166 
CA/C, 170 CA/C, 165 C/CA, and 169 C/CA. The QM region (over 200 atoms) was 
treated with the ωB97X-D functional 69 and a 6-31G* basis set. QM/MM minimizations 
were carried out with the Q-Chem /CHARMM QM/MM interface 31-33.  
The characterization of the low barrier hydrogen bond between Ser70 and Lys73 
was further elucidated by computing the energy barrier of the proton transfer between 
these two residues. During state I’s QM/MM minimization charged Lys73 becomes 
neutral as the hydrogen spontaneously transfers to the Ser70 to stabilize the excess 
negative charge. It is state I’s QM/MM minimized structure that most closely resembles 
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the experimental crystal structure active site; therefore, it is the starting structure for the 
RPATH 34+RESD computations30 used to compute the barrier.  The QM region used for 
the reaction path calculations is the same as the QM/MM minimizations with the 
replicated region defined to be 6.5 Å around the QM region. The reaction pathway was 
constructed by defining two replicas. Replica 1 is defined as the reactant: neutral Ser70 
and Lys73 (i.e., no restraints on hydrogen position). The hydrogen is then restrained to 
move along the reaction path using a linear combination of distances:  δ = dSer70 O - Ser70 H - 
dSer70 H - Lys73 N to the product state: charged Ser70 and Lys73. Replica 2 is defined as a point 
along the reaction pathway as δ is increased by 0.1 Å; this process is repeated until the 
proton transfer is complete. Replica 1 and replica 2 were minimized with δ ranging from 
-0.52 Å - 0.28 Å. QM/MM single point energies were recomputed for the entire pathway 
using the ωB97X-D/6-311++G** level 69,70 of theory. A previously established method35 
used to determine highly accurate low barrier hydrogen bond energy barriers was 
replicated in the present work. The test set in that work included malonaldehyde and 
seven of its derivatives, herein these were  recomputed at the ωB97X-D/6-311++G** 
level of theory to obtain a new linear regression (∆Ebcorr = 1.10∆EbωB97X-D + 0.09) that was 
used to predict the proton transfer barrier with improved (i.e., approximate focal point) 
accuracy. 
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